PRECLINICAL CHARACTERIZATION OF NOVEL CYCLOPHILIN INHIBITORS BASED ON THE POLYKETIDE, SANGLIFEHRIN

被引:0
|
作者
Moss, S. J. [2 ]
Bobardt, M. [1 ]
Coates, N. [2 ]
Chatterji, U. [1 ]
Foster, T. [2 ]
Gallay, P. [1 ]
Habel, A. [2 ]
Kendrew, S. [2 ]
Leyssen, P. [3 ]
Martin, C. J. [2 ]
Neyts, J. [3 ]
Nur-e-Alam, M. [2 ]
Obeid, S. [3 ]
Paeshuyse, J. [3 ]
Suthar, D. [2 ]
Warneck, T. [2 ]
Wilkinson, B. [2 ]
Gregory, M. A. [2 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
[2] Biot Technol Ltd, Cambridge, England
[3] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
关键词
D O I
10.1016/S0168-8278(11)60791-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
789
引用
收藏
页码:S317 / S317
页数:1
相关论文
共 50 条
  • [31] Discovering novel chemical inhibitors of human cyclophilin A: Virtual screening, synthesis, and bioassay
    Li, J
    Chen, J
    Gui, CS
    Zhang, L
    Qin, Y
    Xu, Q
    Zhang, J
    Liu, H
    Shen, X
    Jiang, HL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (07) : 2209 - 2224
  • [32] Preclinical characterization of the pharmacokinetic-pharmacodynamics-efficacy relationship of novel allosteric SHP2 inhibitors
    Pu, Minying
    La Bonte, Laura R.
    Spence, Stan
    Hsiao, Kathy
    Liu, Shumei
    Firestone, Brant
    Wang, Ping
    Fortin, Pascal D.
    Chen, Ying-Nan P.
    LaMarche, Matthew J.
    Meyer, Matthew J.
    [J]. CANCER RESEARCH, 2017, 77
  • [33] Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle
    Zhang, LH
    Liu, JO
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (09): : 5611 - 5618
  • [34] Preclinical evaluation of ASP5286, a novel cyclophilin inhibitor with potent anti-HCV activity
    Sawada, Masae
    Tsujii, Eisaku
    Morishita, Yoshihiko
    Uchida, Masao
    Katsumata, Kiyomitsu
    Maki, Katsuyuki
    Makino, Takuya
    Yoshimura, Seiji
    Yamanaka, Toshio
    Lund, Garry
    Kneteman, Norman M.
    Tyrrell, D. J. Lorne
    [J]. HEPATOLOGY, 2012, 56 : 1078A - 1078A
  • [35] PRECLINICAL CHARACTERIZATION OF NOVEL POTENT NON-NUCLEOSIDE NS5B PALM SITE INHIBITORS
    Thompson, P. A.
    Tran, C. V.
    Murphy, D. E.
    Xiang, A. X.
    Patel, R. A.
    Hou, H.
    Showalter, R. E.
    Liao, X.
    Appleman, J. R.
    Webber, S. E.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S491 - S491
  • [36] PRECLINICAL CHARACTERIZATION OF A NOVEL CLASS OF HIGHLY POTENT SMALL MOLECULE HEPATITIS B AND D VIRUS ENTRY INHIBITORS
    Contreras, Heidi
    Azimova, Dinara
    Tan, Joseph
    Unchwaniwala, Nuruddin
    Guo, Lida
    Shen, Michael
    Yu, Jiaxin
    Windisch, Marc P.
    Xu, Xiang
    Perron, Michel
    Walker, Michael
    Delaney, William
    Zhong, Min
    [J]. HEPATOLOGY, 2022, 76 : S259 - S259
  • [37] Discovery and preclinical characterization of a series of novel JAK2 small molecule inhibitors for the treatment of myeloproliferative diseases
    Jessen, K. A.
    Leonard, S.
    Froning, K.
    Tang, C.
    Smith, C.
    Ellis, D.
    Sperry, S.
    Gessert, S.
    Reich, S.
    Buchanan, S. G.
    [J]. EJC SUPPLEMENTS, 2008, 6 (12): : 177 - 177
  • [38] Preclinical stereoselective disposition and toxicokinetics of two novel MET inhibitors
    Liederer, Bianca M.
    Liu, Xingrong
    Berezhkovskiy, Leonid M.
    Cain, Gary
    Ding, Xiao
    Gaudino, John
    Kaus, Robert
    Plise, Emile G.
    Sutherlin, Daniel P.
    Harstad, Eric B.
    [J]. XENOBIOTICA, 2012, 42 (05) : 456 - 465
  • [39] Preclinical profile of novel and potent small molecule inhibitors of PARG
    Patra, Sukanya
    Pothuganti, Manoj
    Kummari, Githavani
    Sankeshi, Venu
    Kapaka, Jyothipriya
    Karche, Navnath
    Mekala, Ramamohan
    Viswanadha, Srikant
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [40] Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity
    Green, Simon R.
    Wilson, Caroline
    Eadsforth, Thomas C.
    Punekar, Avinash S.
    Tamaki, Fabio K.
    Wood, Gavin
    Caldwell, Nicola
    Forte, Barbara
    Norcross, Neil R.
    Kiczun, Michael
    Post, John M.
    Lopez-Roman, Eva Maria
    Engelhart, Curtis A.
    Lukac, Iva
    Zuccotto, Fabio
    Epemolu, Ola
    Boshoff, Helena I. M.
    Schnappinger, Dirk
    Walpole, Chris
    Gilbert, Ian H.
    Read, Kevin D.
    Wyatt, Paul G.
    Baragana, Beatriz
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (22) : 15380 - 15408